Role of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy
Author Information
Author(s): Ghosh Joydeep MD, FACC, Francis Johnson MBBS, MD, DM, Maron Barry J MD, FACC
Primary Institution: Mount Sinai School of Medicine, Maimonides Medical Center, Brooklyn, New York, USA
Hypothesis
Identifying high-risk patients for primary prevention of sudden cardiac death in hypertrophic cardiomyopathy is challenging.
Conclusion
Implantable cardioverter defibrillators are crucial for preventing sudden cardiac death in patients with hypertrophic cardiomyopathy.
Supporting Evidence
- Hypertrophic cardiomyopathy is the most common genetically inherited cardiac disorder.
- Sudden cardiac death is the most devastating consequence of hypertrophic cardiomyopathy.
- ICDs have shown efficacy in preventing sudden death in patients with hypertrophic cardiomyopathy.
Takeaway
Doctors use special devices called defibrillators to help people with a heart problem called hypertrophic cardiomyopathy, which can cause sudden heart attacks.
Methodology
The article discusses risk stratification assessments and the use of ICDs in patients with hypertrophic cardiomyopathy.
Limitations
There is uncertainty regarding the number of risk factors needed to justify an ICD implant.
Participant Demographics
Hypertrophic cardiomyopathy patients, including adolescents and young adults.
Want to read the original?
Access the complete publication on the publisher's website